SCHEMBL6450028

SCHEMBL6450028

Oc1ccccc1-c1nnc(-c2ccccc2)o1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 12/20 0.69
NPC1 O15118 11/20 0.69
ALDH1A1 P00352 8/20 0.69
KDM4E B2RXH2 6/20 0.69
HSD17B10 Q99714 6/20 0.69
POLB P06746 2/20 0.69
CYP1A2 P05177 1/20 0.69
CYP2C19 P33261 1/20 0.69
SMN1; SMN2 Q16637 7/20 0.65
HPGD P15428 8/20 0.62
TSHR P16473 4/20 0.62
GAA P10253 1/20 0.59
NFKB1 P19838 3/20 0.57
NFKB2 Q00653 3/20 0.57
RELA Q04206 3/20 0.57
MAPT P10636 2/20 0.57
ATR Q13535 1/20 0.57
LMNA P02545 1/20 0.57
ATAD2 Q6PL18 1/20 0.55
CASP3 P42574 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28038904 0.98 RAB9A (0.67) RAB9ANPC1ALDH1A1KDM4EHSD17B10
SCHEMBL27628825 0.98 RAB9A (0.67) RAB9ANPC1ALDH1A1KDM4EHSD17B10
SCHEMBL27604284 0.98 RAB9A (0.67) RAB9ANPC1ALDH1A1KDM4EHSD17B10
SCHEMBL5453348 0.98 RAB9A (0.67) RAB9ANPC1ALDH1A1KDM4EHSD17B10
SCHEMBL27477883 0.96 RAB9A (0.69) RAB9ANPC1ALDH1A1KDM4EHSD17B10
SCHEMBL27620643 0.95 RAB9A (0.68) RAB9ANPC1ALDH1A1KDM4EHSD17B10
SCHEMBL27620651 0.95 RAB9A (0.68) RAB9ANPC1ALDH1A1KDM4EHSD17B10
SCHEMBL9737555 0.90 NPC1 (0.64) RAB9ANPC1ALDH1A1KDM4EHSD17B10
SCHEMBL12171404 0.85 NPC1 (0.73) RAB9ANPC1ALDH1A1KDM4EHSD17B10
SCHEMBL23288084 0.84 ALDH1A1 (0.56) RAB9ANPC1ALDH1A1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103367656-A Micro-molecular organic electroluminescence teaching aid capable of being manually assembled BROAD BEIJING ORGANIC OPTOELECTRONIC MATERIALS RES & ENGINEERING CO LTD 2013-10-23 CN claimed
CN-1173004-C Method for preparing organic phosporescence material 中国科学院长春应用化学研究所 2004-10-27 CN claimed
CN-1405267-A Method for preparing organic phosporescence material CHANGCHUN APPLIED CHEMISTRY (CN) 2003-03-26 CN claimed
WO-2024117631-A1 COMPOUND FOR HOLE INJECTION OR TRANSPORT, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME 울산과학기술원 2024-06-06 WO disclosed
WO-2024117630-A1 IRIDIUM COMPOUND AND USE THEREOF AS PHOSPHORESCENT DOPANT FOR ORGANIC ELECTROLUMINESCENT DEVICE 울산과학기술원 2024-06-06 WO disclosed
US-9722183-B2 Display NOVALED GMBH (DE) 2017-08-01 US disclosed
US-20160211461-A1 Electronic or Optoelectronic Device Comprising an Anchored Thin Molecular Layer, Process for its Preparation and Compound Used Therein NOVALED GMBH (DE) 2016-07-21 US disclosed
CN-101679467-B Organometallic complex, composition containing the same, and light-emitting element SEMICONDUCTOR ENERGY LABORATORY CO.,LTD. (JP) 2016-03-02 CN disclosed
CN-103319540-B Organometallic complex, comprises composition and the luminous element of this organometallic complex SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-01-13 CN disclosed
US-20140332790-A1 Display NOVALED GMBH (DE) 2014-11-13 US disclosed
CN-101541916-B light emitting device SEMICONDUCTOR ENERGY LAB 2014-08-06 CN disclosed
CN-101541916-A light emitting device SEMICONDUCTOR ENERGY LAB (JP) 2009-09-23 CN disclosed
US-20070262693-A1 Composite Material, Light-Emitting Element, Light-Emitting Device and Manufacturing Method Thereof SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-11-15 US disclosed
US-20070262693-A1 Composite Material, Light-Emitting Element, Light-Emitting Device and Manufacturing Method Thereof SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-11-15 US disclosed
CN-1708485-A Electroluminescent device CIBA SC HOLDING AG (CH) 2005-12-14 CN disclosed
US-20050075375-A1 Heterocyclic compounds for treating hepatitis C virus ANADYS PHARMACEUTICALS, INC. (US) 2005-04-07 US disclosed
WO-2004110351-A2 HETEROCYCLIC COMPOUNDS FOR TREATING HEPATITIS C VIRUS ANADYS PHARMACEUTICALS, INC. (US) 2004-12-23 WO disclosed
CN-1173004-C Method for preparing organic phosporescence material 中国科学院长春应用化学研究所 2004-10-27 CN disclosed
CN-1405267-A Method for preparing organic phosporescence material CHANGCHUN APPLIED CHEMISTRY (CN) 2003-03-26 CN disclosed
US-6232050-B1 WHEREIN AT LEAST THREE ORGANIC LIGHT EMITTING DEVICES ARE IN DOT ARRAY STATE EACH HAVING PEAK WAVELENGTH OF EMISSION SPECTRUM WITHIN THE WAVELENGTH REGION CORRESPONDING TO THE SPECTRAL SENSITIVITY OF EACH PHOTOSENSITIVE LAYER FUJI PHOTO FILM CO., LTD. (JP) 2001-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160211461-A1 Electronic or Optoelectronic Device Comprising an Anchored Thin Molecular Layer, Process for its Preparation and Compound Used Therein EPCAM, OR10J3, OR51E2 RAB9A 1139/4885NPC1 4283/4885ALDH1A1 1046/4885
US-20050075375-A1 Heterocyclic compounds for treating hepatitis C virus HAVCR2, HCCS, LIPC RAB9A 2483/4885NPC1 59/4885ALDH1A1 287/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.